18β-glycyrrhetinic acid inhibits migration and invasion of human gastric cancer cells via the ROS/PKC-α/ERK pathway

J Nat Med. 2018 Jan;72(1):252-259. doi: 10.1007/s11418-017-1145-y. Epub 2017 Nov 2.

Abstract

18β-glycyrrhetinic acid (18β-GA) is a bioactive component of licorice root which exerts pharmacological activities including anti-inflammatory, antiviral, anti-oxidative and anti-cancer effects. The current study further investigated the molecular mechanisms associated with the inhibitory effects of 18β-GA on tumor metastasis in human gastric cancer cells. The results indicated that 18β-GA significantly reduced invasion and migration activities and suppressed MMP-2 and 9 activities on SGC-7901cells in a dose-dependent manner. Further study showed 18β-GA upregulated E-cadherin expression but downregulated vimentin expression. The results also showed that 18β-GA inhibited ROS formation, PKC-α expression and the phosphorylation of ERK in a dose-dependent manner. In conclusion, this study revealed that 18β-GA inhibits migration and invasion via the ROS/PKC-α/ERK signaling pathway in gastric cancer cells. This suggests that 18β-GA has the potential to be used as an effective chemopreventive agent for the prevention of gastric cancer metastasis.

Keywords: 18β-glycyrrhetinic acid; Gastric cancer; Invasion; Migration; ROS.

MeSH terms

  • Cell Movement
  • Glycyrrhetinic Acid / analogs & derivatives*
  • Glycyrrhetinic Acid / chemistry
  • Humans
  • MAP Kinase Signaling System / drug effects
  • Neoplasm Invasiveness
  • Reactive Oxygen Species / metabolism*
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / pathology

Substances

  • Reactive Oxygen Species
  • 18alpha-glycyrrhetinic acid
  • Glycyrrhetinic Acid